We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Sphere Fluidics Introduces New Cyto-Mine Studio Software Suite
Product News

Sphere Fluidics Introduces New Cyto-Mine Studio Software Suite

Sphere Fluidics Introduces New Cyto-Mine Studio Software Suite
Product News

Sphere Fluidics Introduces New Cyto-Mine Studio Software Suite

Cyto-Mine Data Analysis Package

Want a FREE PDF version of This Product News?

Complete the form below and we will email you a PDF version of "Sphere Fluidics Introduces New Cyto-Mine Studio Software Suite"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Sphere Fluidics, a company commercializing single cell analysis systems underpinned by its patented picodroplet technology, today introduced Cyto-Mine® Studio Software Suite, an updated software for its innovative Cyto-Mine Single Cell Analysis System. The software works alongside industry-standard robotic platforms and corporate databases to improve antibody discovery and cell line development workflows.

Sphere Fluidics’ Cyto-Mine is an automated platform which integrates single cell screening, sorting, isolation and clone verification. Its Cyto-Mine Studio Software Suite has updated features and user interfaces for the Cyto-Mine Instrument Control Software and the off-line Cyto-Mine Data Analysis Software. It has an application programming interface (API) that enables easy communication with many industry-standard robotic platforms and links to corporate databases for easy data transfer, and includes features such as single cell dispensing to individual wells of 96- and 384-well microtiter plates and software data outputs from single cell imaging analysis.

Dr Rob Marchmont, Director of Sales and Marketing, Sphere Fluidics, said: “Developed with feedback from Sphere Fluidics’ customers, the new software has user-friendly and intuitive navigation, is secure and has programming features to allow scientists to easily monitor and run industry-standard workflows to find new rare antibody-producing cells and high-expressing cells from CHO cell lines or transfection pools. We are now updating our installed systems in Asia, Europe and the US with favorable customer feedback.”

Dr Marian Rehak, Director of R&D, Sphere Fluidics, said: “The new software is robust and brings updated features to the Cyto-Mine platform, providing high-throughput single cell analysis and monoclonality assurance for antibody discovery and cell line development. Cyto-Mine can process small numbers (e.g. a hundred thousand) of cells for monoclonality assurance through to 40 million cells for high-throughput antibody discovery. Inclusion of single cell imaging at various check points and data outputs is particularly powerful for monoclonality assurance.”
Advertisement